Regulations.gov document
Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure…
Notice · FDA-2015-N-0684 · posted Jun 10, 2015
Key facts
| Document ID | FDA-2015-N-0684-0010 |
|---|---|
| Title | Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure In Vivo Bioequivalence of Product Performance and Quality of Non-Systemically Absorbed Drug Products for Animals; Reopening of the Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2015-N-0684 |
| Posted | Jun 10, 2015 |
| Federal Register citation | FR 80 32963 |
| FR document number | 2015-14101 |
| Comment period opens | Jun 10, 2015 |
| Comments due | Aug 11, 2015 |
| Effective date | Jun 10, 2015 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: